Authored By: Sarah
26 Jun 2024

 Sciatica Treatment Market Size to grow by USD 3089.08 million between 2023-2027

According to a research report “ Sciatica Treatment Market” by End-user (Hospital, Clinics, Others) Product (Non-surgical treatment, Surgical treatment) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2027 published by Technavio, the market size is estimated to grow by USD 3089.08 million, at a CAGR of  4.83% during the forecast period. In the realm of healthcare, sciatica, a condition characterized by pain in the lower back and legs due to compression of the sciatic nerve, is a significant concern. Misdiagnosis is common, with sciatica often mistaken for general back pain. To mitigate this issue, various organizations, both governmental and nongovernmental, are spearheading initiatives to boost public awareness and expedite diagnosis. In the United States, OrthoInfo, an educational platform of the American Academy of Orthopaedic Surgeons (AAOS), offers informative articles, videos, and animations on sciatica. Similarly, HCA Healthcare UK is committed to educating the public in the UK about sciatica symptoms, screening, diagnosis, and potential treatment options., an Australian healthcare website, provides valuable and pertinent health information on various health issues, including sciatica. These efforts aim to ensure that individuals receive accurate information and timely diagnosis, thereby improving overall patient care.

Browse market data tables, figures, and in-depth TOC on “Sciatica Treatment Market” by End-user (Hospital, Clinics, Others) Product (Non-surgical treatment, Surgical treatment) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2027. Download Free Sample


By End-user, the Hospital segment is projected to dominate the market size in 2024

In the sciatica treatment market, there is a growing preference for non-surgical options due to the perceived risks, complications, and extended recovery time associated with surgical interventions. Advancements in non-invasive modalities, such as physical therapy, chiropractic care, acupuncture, and epidural steroid injections, offer effective alternatives for managing sciatica symptoms. These treatments typically involve shorter recovery periods and minimal downtime, making them an attractive choice for individuals seeking to resume their daily activities as soon as possible. Notable non-surgical treatments for sciatica include epidural corticosteroid injections, nonsteroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, narcotics, tricyclic antidepressants, anti-seizure medications, and various physical therapies.

By Product, Non-surgical treatment  segment is expected to hold the largest market size for the year 2024

The global sciatica treatment market is witnessing significant growth, with hospitals leading the end-user segment. Hospitals are pivotal in the market due to the high volume of sciatica treatments administered and the availability of specialized medical expertise. Common surgical procedures for sciatica include microdiscectomy and laminectomy. Microdiscectomy, which addresses herniated discs or bone spurs to alleviate pressure on the sciatic nerve, is a popular choice. The rising prevalence of sciatica, with an estimated 843 million cases projected by 2050 according to WHO data, is driving market expansion.

North America is forecasted to hold the largest market size by region in 2024

In the global sciatica treatment market, North America held the largest share in 2023, driven by heightened awareness of the condition and strategic business collaborations. The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) and HealthLink BC are leading initiatives to educate the public in the US and Canada, respectively, about sciatica's signs, causes, diagnosis, and standard treatments. Additionally, the region's high incidence of sports injuries contributes significantly to market expansion.

The Sciatica Treatment Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Amneal Pharmaceuticals Inc.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Dr Reddys Laboratories Ltd.
  • Elam Pharma Pvt. Ltd.
  • Fresenius SE and Co. KGaA
  • Glenmark Pharmaceuticals Ltd.
  • Hikma Pharmaceuticals Plc
  • Johnson and Johnson
  • Lupin Ltd.
  • Novartis AG
  • Omega Laser Systems Ltd.
  • Ozone Pharmaceuticals Ltd.
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Sciatica Treatment Market has witnessed significant growth due to the increasing incidence of sciatica, a condition characterized by pain, burning sensation, stiffness, and weakness in the lower spine, hips, legs, and buttocks. This condition is often caused by compression or irritation of the sciatic nerve, which runs from the lower back down to the legs. Safety and efficacy are key considerations in the treatment of sciatica. Medications such as non-steroidal anti-inflammatory drugs (NSAIDs) and opioids are commonly used to provide relief from pain. However, their long-term use can have side effects and risks. Other treatments include physical therapy, chiropractic care, acupuncture, and surgery. The safety and efficacy of these treatments vary, and healthcare providers often recommend a combination of approaches. Sciatica can be caused by various conditions such as bone spurs, spinal stenosis, spondylolisthesis, osteoarthritis, diabetes, prolonged sitting, obesity, age-related changes, and herniated discs. Proper diagnosis is crucial to determine the most effective treatment. Symptoms of sciatica include lower back pain, radiating pain in the legs, hip pain, and numbness or tingling in the buttocks. If left untreated, sciatica can lead to long-term disability and decreased quality of life. Overall, the sciatica treatment market is expected to continue growing due to the increasing prevalence of conditions that cause sciatica and the need for effective and safe treatment options.

Market Research Overview

The Sciatica Treatment Market encompasses a range of specialized services and products designed to alleviate the pain and irritation caused by sciatica, a condition characterized by the compression or irritation of the sciatic nerve. This nerve, which runs from the lower spine down to the legs and feet, can cause symptoms such as burning sensation, pain, stiffness, and muscle weakness. The market includes specialty hospitals, clinics, and home care services, as well as pharmaceutical manufacturing and supply chain solutions. Hospitals offer sciatica treatment through surgery, physical therapy, and medication in the form of anesthetics, pain killers (including anticonvulsants, antidepressants, steroids, and analgesics), and NSAIDs. Home care services provide alternative treatment options, such as chiropractic devices and physical therapy. Sciatica surgery, while a last resort, is an option for severe cases. However, it carries risks such as infections and bleeding. The safety and efficacy of various sciatica treatments are continually being evaluated through clinical trial programs. The sciatica treatment market is driven by the high incidence of lower back pain, which affects a significant portion of the human population, particularly the geriatric population, those with occupations that require prolonged sitting, and individuals with conditions such as degenerative disk disease, spinal stenosis, spondylolisthesis, osteoarthritis, diabetes, obesity, and age-related changes. Symptoms can manifest in the lower spine, hips, legs, and buttocks. In summary, the sciatica treatment market offers a range of solutions to address the pain and irritation caused by sciatica, including hospital services, home care, medication, and surgery. The market continues to evolve as researchers and healthcare providers seek to improve safety, efficacy, and patient relief.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!